» Articles » PMID: 12964941

Binding of Phosphatidylinositol 3,4,5-trisphosphate to the Pleckstrin Homology Domain of Protein Kinase B Induces a Conformational Change

Overview
Journal Biochem J
Specialty Biochemistry
Date 2003 Sep 11
PMID 12964941
Citations 123
Authors
Affiliations
Soon will be listed here.
Abstract

Protein kinase B (PKB/Akt) is a key regulator of cell growth, proliferation and metabolism. It possesses an N-terminal pleckstrin homology (PH) domain that interacts with equal affinity with the second messengers PtdIns(3,4,5)P3 and PtdIns(3,4)P2, generated through insulin and growth factor-mediated activation of phosphoinositide 3-kinase (PI3K). The binding of PKB to PtdIns(3,4,5)P3/PtdIns(3,4)P2 recruits PKB from the cytosol to the plasma membrane and is also thought to induce a conformational change that converts PKB into a substrate that can be activated by the phosphoinositide-dependent kinase 1 (PDK1). In this study we describe two high-resolution crystal structures of the PH domain of PKBalpha in a noncomplexed form and compare this to a new atomic resolution (0.98 A, where 1 A=0.1 nm) structure of the PH domain of PKBalpha complexed to Ins(1,3,4,5)P4, the head group of PtdIns(3,4,5)P3. Remarkably, in contrast to all other PH domains crystallized so far, our data suggest that binding of Ins(1,3,4,5)P4 to the PH domain of PKB, induces a large conformational change. This is characterized by marked changes in certain residues making up the phosphoinositide-binding site, formation of a short a-helix in variable loop 2, and a movement of variable loop 3 away from the lipid-binding site. Solution studies with CD also provided evidence of conformational changes taking place upon binding of Ins(1,3,4,5)P4 to the PH domain of PKB. Our data provides the first structural insight into the mechanism by which the interaction of PKB with PtdIns(3,4,5)P3/PtdIns(3,4)P2 induces conformational changes that could enable PKB to be activated by PDK1.

Citing Articles

Structural insights of AKT and its activation mechanism for drug development.

Kumar B, Kabekkodu S, Pai K Mol Divers. 2025; .

PMID: 40009150 DOI: 10.1007/s11030-025-11132-7.


A small signaling domain controls PPIP5K phosphatase activity in phosphate homeostasis.

Raia P, Lee K, Bartsch S, Rico-Resendiz F, Portugal-Calisto D, Vadas O Nat Commun. 2025; 16(1):1753.

PMID: 39966396 PMC: 11836120. DOI: 10.1038/s41467-025-56937-0.


Zinc ions activate AKT and promote prostate cancer cell proliferation via disrupting AKT intramolecular interaction.

Wang K, Chen M, Yan S, Han Y, Yuan H, Liu Q Oncogene. 2024; 44(1):8-18.

PMID: 39438763 DOI: 10.1038/s41388-024-03195-x.


Integrating UPLC-Q-TOF-MS and Network Pharmacology to Explore the Potential Mechanisms of Pall. in the Treatment of Blood Stasis Syndrome.

Ma M, Du Q, Shi S, Lv J, Zhang W, Ge D Molecules. 2024; 29(13).

PMID: 38998977 PMC: 11243510. DOI: 10.3390/molecules29133019.


Network Pharmacology Based Elucidation of Molecular Mechanisms of Laoke Formula for Treatment of Advanced Non-Small Cell Lung Cancer.

Feng Y, Liu J, Xue Y, Liu D, Wu X Chin J Integr Med. 2024; 30(11):984-992.

PMID: 38941043 DOI: 10.1007/s11655-024-3717-5.


References
1.
Vriend G . WHAT IF: a molecular modeling and drug design program. J Mol Graph. 1990; 8(1):52-6, 29. DOI: 10.1016/0263-7855(90)80070-v. View

2.
Calleja V, Ameer-Beg S, Vojnovic B, Woscholski R, Downward J, Larijani B . Monitoring conformational changes of proteins in cells by fluorescence lifetime imaging microscopy. Biochem J. 2003; 372(Pt 1):33-40. PMC: 1223389. DOI: 10.1042/BJ20030358. View

3.
Nicholls A, Sharp K, Honig B . Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins. 1991; 11(4):281-96. DOI: 10.1002/prot.340110407. View

4.
Sreerama N, Woody R . A self-consistent method for the analysis of protein secondary structure from circular dichroism. Anal Biochem. 1993; 209(1):32-44. DOI: 10.1006/abio.1993.1079. View

5.
Freskgard P, Martensson L, Jonasson P, Jonsson B, Carlsson U . Assignment of the contribution of the tryptophan residues to the circular dichroism spectrum of human carbonic anhydrase II. Biochemistry. 1994; 33(47):14281-8. DOI: 10.1021/bi00251a041. View